Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2026-04-06 @ 3:05 PM
Study NCT ID:
NCT06637306
Status:
RECRUITING
Last Update Posted:
2025-03-26
First Post:
2024-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Sponsor:
Rima Patel
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PRMC-24-125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None